| Literature DB >> 18350309 |
Anders I Seldén1, Cecilia Lundholm, Niklas Johansson, Håkan Wingfors.
Abstract
OBJECTIVES: To estimate the internal PCB level in Swedish workers specialised in PCB abatement in buildings and to measure possible effects of PCB on thyroid function and aspects of the immune system.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18350309 PMCID: PMC2467502 DOI: 10.1007/s00420-008-0313-5
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Some background characteristics of the study population
| Characteristic | Abatement workers | Controls |
|---|---|---|
| Age, years | ||
| Range | 24–57 | 20–46 |
| Median | 32 | 31 |
| Body mass index kg/m2 | ||
| Range | 20.1–34.3 | 20.9–31.4 |
| Median | 26.0 | 24.9 |
| Tobacco habits | ||
| Non-smoker | 17 (47) | 27 (82) |
| Ex-smoker | 5 (14) | 3 (9) |
| Smoker | 14 (39) | 3 (9) |
| Moist snuff (smokeless tobacco) user | 20 (56) | 13 (39) |
| Fatty fish meals | ||
| Rarely/never | 32 (89) | 27 (82) |
| 1–2/month | 4 (11) | 6 (18) |
| ≥1/week | 0 (0) | 0 (0) |
| Current work dusty | ||
| No | 1 (3) | 0 (0) |
| Yes | 35 (97) | 33 (100) |
| Respiratory protection in dusty work | ||
| None | 8 (22) | 27 (82) |
| Filter mask | 4 (11) | 6 (18) |
| Filter mask/self-contained respirator | 6 (17) | 0 (0) |
| Self-contained respirator | 18 (50) | 0 (0) |
| Self-assessed general health | ||
| Good | 34 (94) | 30 (91) |
Geometric mean and range of PCB, HCB and p, p' -DDE in plasma of PCB abatement workers (n = 36) and controls (n = 33) on a wet weight basis (ng/g) and after lipid adjustment (ng/g lipid)
| Compound | Wet weight | Lipid-adjusted | ||||||
|---|---|---|---|---|---|---|---|---|
| Abatement workers | Controls | Abatement workers | Controls | |||||
| GM | Range | GM | Range | GM | Range | GM | Range | |
| PCB (IUPACa) | ||||||||
| 28 | 0.052*** | 0.0029–0.39 | 0.011 | 0.002–0.032 | 13*** | 0.7–110 | 3.2 | 0.2–28 |
| 52 | 0.023*** | 0.001–0.20 | 0.0037 | 0.0009–0.037 | 5.5*** | 0.1–43 | 1.0 | 0.2–18 |
| 47 | 0.015*** | 0.0029–0.087 | 0.0036 | 0.001–0.012 | 3.7*** | 0.6–18 | 1.0 | 0.2–4.4 |
| 44 | 0.013*** | <0.001–0.16 | 0.0010 | 0.00051–0.019 | 3.1*** | <0.2–35 | 0.26 | <0.1–9.3 |
| 74 | 0.096*** | 0.014–0.56 | 0.012 | 0.005–0.028 | 24*** | 3.0–160 | 3.5 | 1.5–11 |
| 70 | 0.0087*** | <0.001–0.17 | 0.0014 | 0.00039–0.021 | 2.1*** | <0.2–41 | 0.38 | <0.1–10 |
| 66 | 0.065*** | 0.0041–0.76 | 0.0028 | 0.001–0.011 | 16*** | 1.1–220 | 0.8 | 0.2–2.7 |
| 56/60 | 0.036*** | <0.001–0.40 | 0.0012 | 0.00089–0.0048 | 8.4*** | <0.1–115 | 0.31 | <0.1–1.5 |
| 95 | 0.028*** | 0.0018–0.19 | 0.0024 | <0.001–0.011 | 6.9*** | 0.65–52 | 0.70 | <0.3–2.7 |
| 101 | 0.038*** | 0.0044–0.32 | 0.0055 | 0.001–0.041 | 9.3*** | 0.8–70 | 1.6 | 0.3–20 |
| 99 | 0.053*** | 0.011–0.20 | 0.018 | 0.008–0.048 | 13*** | 3.4–59 | 5.2 | 2.9–15 |
| 87 | 0.010*** | <0.001–0.076 | 0.0012 | 0.00075–0.0047 | 0.92*** | 0.27–16 | 0.30 | <0.1–2.3 |
| 110 | 0.028*** | 0.0002–0.24 | 0.0025 | 0.00083–0.014 | 6.9*** | 0.54–52 | 0.71 | 0.23–5.4 |
| 118 | 0.11*** | 0.018–0.59 | 0.033 | 0.016–0.084 | 28*** | 5.2–170 | 9.4 | 4.2–64 |
| 105 | 0.034*** | 0.066–0.21 | 0.0061 | 0.0015–0.020 | 8.4*** | 1.7–61 | 1.8 | 0.5–10 |
| 153 | 0.51*** | 0.13–1.6 | 0.29 | 0.14–0.77 | 130** | 37–540 | 84 | 31–360 |
| 138 | 0.46*** | 0.10–1.5 | 0.21 | 0.10–0.55 | 110*** | 29–640 | 59 | 25–200 |
| 182/187 | 0.086*** | 0.018–0.34 | 0.041 | <0.003–0.12 | 16** | 5.1–110 | 11.8 | <2.1–92 |
| 180 | 0.35** | 0.097–1.4 | 0.24 | 0.12–0.64 | 87 | 28–330 | 70 | 25–410 |
| ∑7 PCB | 1.6*** | 0.40–4.9 | 0.80 | 0.40–2.0 | 410*** | 120–1800 | 230 | 90–1100 |
| ∑19 PCB | 2.3*** | 0.56–7.8 | 0.90 | 0.45–2.2 | 580*** | 160–2200 | 260 | 110–1200 |
| HCB | 0.16* | 0.067–0.32 | 0.13 | 0.063–0.24 | 39 | 19–98 | 37 | 16–140 |
|
| 0.96*** | 0.31–12 | 0.54 | 0.23–1.8 | 240* | 90–3100 | 160 | 35–410 |
| Plasma lipidsb (%) | 0.42 (0.10) | 0.23–0.64 | 0.37 (0.14) | 0.12–0.73 | ||||
PCB congeners sorted as they appeared chronologically in the chromatograms within each homologue group (tri to hepta)
aInternational Union of Applied and Pure Chemistry
bArithmetic mean (standard deviation)
* P < 0.05, ** P < 0.01, *** P < 0.001
Levels of PCB, HCB and p, p′-DDE in baseline and follow-up samples (10 months later) of plasma from PCB abatement workers (n = 25). Geometric mean (GM), range of lipid-adjusted values (ng/g lipid) and correlation (Pearson) between the samples
| Compound | Baseline | Follow-up | |||
|---|---|---|---|---|---|
| GM | Range | GM | Range | rb | |
| PCB (IUPACa) | |||||
| 28 | 18 | 2.9–110 | 16 | 2.4–87 | 0.90 |
| 52 | 7.7 | 0.91–43 | 4.0*** | 0.58–20 | 0.81 |
| 47 | 4.8 | 0.56–18 | 3.8* | 0.63–15 | 0.84 |
| 44 | 4.0 | <0.2–35 | 2.1** | 0.13–12 | 0.66 |
| 74 | 30 | 3.0–160 | 33 | 3.4–150 | 0.94 |
| 70 | 2.8 | <0.2–41 | 1.1*** | 0.28–4.4 | 0.58 |
| 66 | 25 | 1.2–220 | 25 | 1.2–170 | 0.91 |
| 56/60 | 12 | <0.1–115 | 15 | 0.97–86 | 0.91 |
| 95 | 9.8 | 1.2–37 | 8.2* | 0.80–38 | 0.91 |
| 101 | 14 | 2.5–62 | 10* | 1.0–68 | 0.86 |
| 99 | 14 | 3.4–59 | 14 | 2.9–48 | 0.91 |
| 87 | 3.5 | 0.54–16 | 2.6** | 0.35–8.8 | 0.88 |
| 110 | 9.5 | 1.5–52 | 6.3** | 0.75–38 | 0.83 |
| 118 | 32 | 5.2–170 | 35 | 4.3–140 | 0.90 |
| 105 | 10 | 1.7–61 | 9.5 | 1.7–46 | 0.89 |
| 153 | 120 | 37–410 | 130 | 33–380 | 0.91 |
| 138 | 110 | 36–370 | 120 | 23–370 | 0.88 |
| 182/187 | 20 | 6.0–79 | 21 | 5.0–75 | 0.91 |
| 180 | 81 | 29–330 | 89 | 23–340 | 0.88 |
| ∑7 PCB | 410 | 130–1400 | 430 | 87–1200 | 0.87 |
| ∑19 PCB | 600 | 170–2300 | 610 | 110–1900 | 0.77 |
| HCB | 40 | 19–98 | 36 | 20–79 | 0.77 |
|
| 240 | 100–3100 | 230 | 77–2900 | 0.89 |
aInternational Union of Pure and Applied Chemistry
bAll correlations significant at P < 0.001 except PCB #70 at P = 0.003, Spearman’s rho (r s)
* P < 0.05, ** P < 0.01, *** P < 0.001
Levels of PCB and HCB in plasma from the controls of the current study and a group of historical controls of construction material industry and food industry workers (Seldén et al. 1997). Geometric means of lipid-adjusted values (ng/g lipid)
| Compound | Current controls | Historical controls |
|---|---|---|
| PCB (IUPACa) | ||
| 28 | 3.2* | 2.1 |
| 52 | 1.0 | 1.0 |
| 101 | 1.6*** | 3.0 |
| 118 | 9.4*** | 27 |
| 153 | 84*** | 230 |
| 138 | 59*** | 160 |
| 180 | 70*** | 140 |
| ∑7 PCB | 230*** | 580 |
| HCB | 37 | 29 |
aInternational Union of Pure and Applied Chemistry
* P < 0.05, *** P < 0.001
Serum levels of triiodothyronine (S-T3), free thyroxine (S-FT4) and thyrotropin (S-TSH) in PCB abatement workers and controls (arithmetic mean, AM, and standard deviation, SD)
| Thyroid hormone | Reference values | Abatement workers | Controls | ||
|---|---|---|---|---|---|
| AM (SD) | Range | AM (SD) | Range | ||
| S-T3 nmol/l | 1.3–2.5 | 2.20 (0.26) | 1.7–2.9 | 2.09 (0.26) | 1.6–2.7 |
| S-FT4 pmol/l | 9–20 | 14.2 (2.0) | 10.8–18.6 | 13.9 (1.6) | 11.9–19.1 |
| S-TSH mU/l | 0.5–4.2 | 1.68 (0.62) | 0.22–2.9 | 1.71 (0.98) | 0.5–5.3 |
Spearman’s correlation between PCB in plasma (ng/g lipid) and thyroid hormones S-T3 and S-FT4, and thyrotropin (S-TSH), for PCB abatement workers and controls combined (n = 68)
| PCB # (IUPACa) | Hormone | ||
|---|---|---|---|
| S-T3 | S-FT4 | S-TSH | |
| 28 | 0.13 | −0.01 | −0.05 |
| 52 | 0.09 | −0.13 | 0.03 |
| 101 | 0.15 | −0.07 | 0.06 |
| 118 | 0.11 | 0.02 | −0.04 |
| 153 | 0.01 | −0.07 | −0.04 |
| 138 | 0.07 | −0.05 | −0.03 |
| 180 | −0.09 | −0.08 | −0.13 |
| Σ7 PCB | 0.04 | −0.04 | −0.07 |
| Σ19 PCB | 0.07 | 0.00 | −0.11 |
aInternational Union of Pure and Applied Chemistry
Plasma levels of cytokines (pg/ml) and proportion (%) of samples at or above the limit of quantification (LoQ) in PCB abatement workers (baseline and follow-up) and controls
| Cytokine | LoQ pg/ml | Abatement workers | Controls | ||||
|---|---|---|---|---|---|---|---|
| Baseline | Follow up |
| |||||
| Range | ≥LoQ % | Range | ≥LoQ % | Range | ≥LoQ % | ||
| IL-2 | 2.6 | <2.6–10.7 | 13.9 | <2.6–4.4 | 8.0 | <2.6–29.4 | 9.1 |
| IL-4 | 2.6 | <2.6 | 0.0 | <2.6 | 0.0 | <2.6–55.0 | 3.0 |
| IL-6 | 3.0 | <3.0–34.8 | 30.6 | <3.0–22.7 | 48.0 | <3.0–98.9 | 42.4 |
| IL-10 | 2.8 | <2.8–63.1 | 30.6 | <2.8–87.9 | 64.0 | <2.8–123.2 | 27.3 |
| TNF-α | 2.8 | <2.8–19.2 | 25.0 | <2.8–9.0 | 48.0 | <2.8–63.5 | 24.2 |
| IFN-γ | 7.1 | <7.1–42.5 | 25.0 | <7.1–51.7 | 56.0 | <7.1–188.3 | 24.2 |